Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results October 4, 2021 Relmada Therapeutics Provides Regulatory and Development Updates on Ongoing Late-Stage Clinical Program for REL-1017 for Treatment of Major Depressive Disorder September 17, 2021 Relmada Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit September 3, 2021 Relmada Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference August 10, 2021 Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results August 5, 2021 Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021 July 27, 2021 Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs Oxycodone for Abuse Potential July 20, 2021 Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC June 15, 2021 Relmada Therapeutics to Present Data at the College on Problems of Drug Dependence 83rd Annual Scientific Meeting June 7, 2021 Relmada Therapeutics Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference June 1, 2021 Relmada Therapeutics Announces Participation in Jefferies Virtual Healthcare Conference «...91011121314...»
